| 08:30 – 09:00 |
Welcome coffee |
| 09:00 – 11:00 |
Part 1. Cardiovascular prevention and patient empowerment |
|
Chairs: Dr. Michel Langlois (AZ St. Jan Bruges) and Prof. Ernst Rietzschel (UZ Gent, President BAS)
|
| 09:00 – 09:30 |
Lp(a): What is it? And which are the available treatments?
Prof. Dr. F. Demeure, Department of Cardiology, CHU Namur, Belgium
|
| 09:30 – 10:00 |
Standardization and Quantification of Lp(a)
Dr. M. Langlois, Department of Laboratory Medicine, AZ St. Jan Bruges, Belgium
|
| 10:00 – 10:30 |
Okay, Lp(a) is high, what is next?
Prof. Dr. E. Rietzschel, Department of Cardiology, Ghent University Hospital, Belgium; President of the Belgian Atherosclerosis Society (BAS)
|
| 10:30 – 10:45 |
Oral communication: Best abstract in Clinical Chemistry
|
| 10:45 – 11:10 |
Coffee break |
| 11:10 – 11:50 |
Guided poster tour
|
| 11:50 – 12:45 |
Lunch break |
| 12:45 – 13:30 |
Part 2. Sponsored Satellite symposium |
| 13:30 – 15:50 |
Part 3. Early Detection of Disease in Asymptomatic Individuals |
|
Chairs: TBD
|
| 13:30 – 14:00 |
Population-based 1st-tier Genomic Newborn Screening - Results of BabyDetect Study
Prof. F. Boemer, Biochemical Genetics Laboratory, Newborn Screening Centre, CHU Liège, Belgium
|
| 14:00 – 14:30 |
Optimization of CKD screening strategies by urine test strips using the albumin-creatinine read-out
Dr. M. Oyaert, Department of Laboratory Medicine, Ghent University Hospital, Belgium
|
| 14:30 – 15:40 |
Screening in (gestational) Diabetes
| 14:30 – 14:55 |
Screening gestational diabetes
TBD
|
| 14:55 – 15:20 |
Autoimmunity in diabetes, pre-analytics and analytics (HbA1c, fructosamine)
TBD
|
|
| 15:50 |
Wrap up and end of the 2025 RBSLM Annual Meeting |
